Discovery of naturally occurring transmissible chronic hepatitis B virus infection among macaca fascicularis from mauritius island

Hepatology

Volumn 58, Issue 5, 2013, Pages 1610-1620

  Dupinay, Tatiana ^a,b,c   Gheit, Tarik ^d   Roques, Pierre ^e,f   Cova, Lucyna ^a,b   Chevallier Queyron, Philippe ^a,b,g   Tasahsu, Shin i ^h   Le Grand, Roger ^e,f   Simon, François ⁱ   Cordier, Geneviève ^j   Wakrim, Lahcen ^k   Benjelloun, Soumaya ^k   Trépo, Christian ^a,b,g   Chemin, Isabelle ^a,b  

^a UNIVERSITÉ DE LYON   (France)

^b CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^c PSL RESEARCH UNIVERSITY   (France)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

^g Hospice Civil de Lyon   (France)

^h NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

ⁱ SAINT LOUIS HOSPITAL   (France)

^j UNIVERSITÉ LYON 1   (France)

^k Institut Pasteur du Maroc   (Morocco)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; ASIA; BLOOD SAMPLING; BREEDING; CONTROLLED STUDY; FOLLOW UP; GENE SEQUENCE; GENOME ANALYSIS; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; INOCULATION; LIVER; LIVER CELL; MACACA; MACACA FASCICULARIS; MACACA SYLVANUS; MAURITIUS; MOROCCO; NONHUMAN; NUCLEOTIDE SEQUENCE; PORTUGAL; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; VIRUS LOAD; VIRUS TRANSMISSION;

ALANINE TRANSAMINASE; AMINO ACID SEQUENCE; ANIMALS; DISEASE MODELS, ANIMAL; GENOTYPE; HEPATITIS B, CHRONIC; MACACA FASCICULARIS; MAURITIUS; MOLECULAR SEQUENCE DATA; MONKEY DISEASES; PHYLOGENY;

EID: 84887016912     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26428     Document Type: Article

References (49)

1. Tillmann HL. Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol 2007;13:125-140.
2. Bertoletti A, Ferrari C. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut 2012;61:1754-1764.
3. Michel ML, Deng Q, Mancini-Bourgine M. Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges. J Hepatol 2011;54:1286-1296.
4. Grethe S, Heckel JO, Rietschel W, Hufert FT. Molecular epidemiology of hepatitis B virus variants in nonhuman primates. J Virol 2000;74:5377-5381.
5. MacDonald DM, Holmes EC, Lewis JC, Simmonds P. Detection of hepatitis B virus infection in wild-born chimpanzees (Pan troglodytes verus): phylogenetic relationships with human and other primate genotypes. J Virol 2000;74:4253-4257.
6. Makuwa M, Souquiere S, Clifford SL, Mouinga-Ondeme A, Bawe-Johnson M, Wickings EJ, et al. Identification of hepatitis B virus genome in faecal sample from wild living chimpanzee (Pan troglodytes troglodytes) in Gabon. J Clin Virol 2005;34(Suppl 1):S83-S88.
7. Takahashi K, Brotman B, Usuda S, Mishiro S, Prince AM. Full-genome sequence analyses of hepatitis B virus (HBV) strains recovered from chimpanzees infected in the wild: implications for an origin of HBV. Virology 2000;267:58-64.
8. Takahashi K, Mishiro S, Prince AM. Novel hepatitis B virus strain from a chimpanzee of Central Africa (Pan troglodytes troglodytes) with an unusual antigenicity of the core protein. Intervirology 2001;44:321-326.
9. Vartanian JP, Pineau P, Henry M, Hamilton WD, Muller MN, Wrangham RW, Wain-Hobson S. Identification of a hepatitis B virus genome in wild chimpanzees (Pan troglodytes schweinfurthi) from East Africa indicates a wide geographical dispersion among equatorial African primates. J Virol 2002;76:11155-11158.
10. Verschoor EJ, Warren KS, Langenhuijzen S, Heriyanto, Swan RA, Heeney JL. Analysis of two genomic variants of orang-utan hepadnavirus and their relationship to other primate hepatitis B-like viruses. J Gen Virol 2001;82:893-897.
11. Warren KS, Heeney JL, Swan RA, Heriyanto, Verschoor EJ. A new group of hepadnaviruses naturally infecting orangutans (Pongo pygmaeus). J Virol 1999;73:7860-7865.
12. Lanford RE, Chavez D, Rico-Hesse R, Mootnick A. Hepadnavirus infection in captive gibbons. J Virol 2000;74:2955-2959.
13. Noppornpanth S, Haagmans BL, Bhattarakosol P, Ratanakorn P, Niesters HG, Osterhaus AD, Poovorawan Y. Molecular epidemiology of gibbon hepatitis B virus transmission. J Gen Virol 2003;84:147-155.
14. Norder H, Ebert JW, Fields HA, Mushahwar IK, Magnius LO. Complete sequencing of a gibbon hepatitis B virus genome reveals a unique genotype distantly related to the chimpanzee hepatitis B virus. Virology 1996;218:214-223.
15. Sall AA, Starkman S, Reynes JM, Lay S, Nhim T, Hunt M, et al. Frequent infection of Hylobates pileatus (pileated gibbon) with species-associated variants of hepatitis B virus in Cambodia. J Gen Virol 2005;86:333-337.
16. Lanford RE, Chavez D, Brasky KM, Burns RB, III, Rico-Hesse R. Isolation of a hepadnavirus from the woolly monkey, a New World primate. Proc Natl Acad Sci U S A 1998;95:5757-5761.
17. Starkman SE, MacDonald DM, Lewis JC, Holmes EC, Simmonds P. Geographic and species association of hepatitis B virus genotypes in non-human primates. Virology 2003;314:381-393.
18. Hu X, Margolis HS, Purcell RH, Ebert J, Robertson BH. Identification of hepatitis B virus indigenous to chimpanzees. Proc Natl Acad Sci U S A 2000;97:1661-1664.
19. Makuwa M, Souquiere S, Telfer P, Bourry O, Rouquet P, Kazanji M, et al. Hepatitis viruses in non-human primates. J Med Primatol 2006;35:384-387.
20. Gheit T, Sekkat S, Cova L, Chevallier M, Petit MA, Hantz O, et al. Experimental transfection of Macaca sylvanus with cloned human hepatitis B virus. J Gen Virol 2002;83:1645-1649.
21. Lucifora J, Vincent IE, Berthillon P, Dupinay T, Michelet M, Protzer U, et al. Hepatitis B virus replication in primary macaque hepatocytes: crossing the species barrier toward a new small primate model. Hepatology 2010;51:1954-1960.
22. Jilbert AR, Wu TT, England JM, Hall PM, Carp NZ, O'Connell AP, Mason WS. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J Virol 1992;66:1377-1388.
23. Mrani S, Chemin I, Menouar K, Guillaud O, Pradat P, Borghi G, et al. Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C. J Med Virol 2007;79:1075-1081.
24. Werle-Lapostolle B, Bowden S, Locarnini S, Wursthorn K, Petersen J, Lau G, et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 2004;126:1750-1758.
25. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004;47:289-309.
26. Norder H, Courouce AM, Magnius LO. Molecular basis of hepatitis B virus serotype variations within the four major subtypes. J Gen Virol 1992;73(Pt 12):3141-3145.
27. Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, Maeshiro T, et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol 2009;83:10538-10547.
28. Wursthorn K, Jung M, Riva A, Goodman ZD, Lopez P, Bao W, et al. Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients. Hepatology 2010;52:1611-1620.
29. Warren KS, Niphuis H, Heriyanto, Verschoor EJ, Swan RA, Heeney JL. Seroprevalence of specific viral infections in confiscated orangutans (Pongo pygmaeus). J Med Primatol 1998;27:33-37.
30. Alter HJ, Purcell RH, Gerin JL, London WT, Kaplan PM, McAuliffe VJ, et al. Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen. Infect Immun 1977;16:928-933.
31. Bancroft WH, Snitbhan R, Scott RM, Tingpalapong M, Watson WT, Tanticharoenyos P, et al. Transmission of hepatitis B virus to gibbons by exposure to human saliva containing hepatitis B surface antigen. J Infect Dis 1977;135:79-85.
32. Chemin I, Guillaud O, Queyron PC, Trepo C. Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection. J Hepatol 2009;51:824-825.
33. Lepere-Douard C, Trotard M, Le Seyec J, Gripon P. The first transmembrane domain of the hepatitis B virus large envelope protein is crucial for infectivity. J Virol 2009;83:11819-11829.
34. Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 2012;1:e00049.
35. Lyons S, Sharp C, LeBreton M, Djoko CF, Kiyang JA, Lankester F, et al. Species association of hepatitis B virus (HBV) in non-human apes; evidence for recombination between gorilla and chimpanzee variants. PLoS One 2012;7:e33430.
36. Sussman RW, Tattersall I. Distribution, abundance, and putative ecological strategy of Macaca fascicularis on the island of Mauritius, Southwestern Indian Ocean. Folia Primatologica 1986;46:28-43.
37. Lawler SH, Sussman RW, Taylor LL. Mitochondrial DNA of the Mauritian macaques (Macaca fascicularis): an example of the founder effect. Am J Phys Anthropol 1995;96:133-141.
38. Bonhomme M, Blancher A, Cuartero S, Chikhi L, Crouau-Roy B. Origin and number of founders in an introduced insular primate: estimation from nuclear genetic data. Mol Ecol 2008;17:1009-1019.
39. Tallo T, Tefanova V, Priimagi L, Schmidt J, Katargina O, Michailov M, et al. D2: major subgenotype of hepatitis B virus in Russia and the Baltic region. J Gen Virol 2008;89:1829-1839.
40. Pujol FH, Navas MC, Hainaut P, Chemin I. Worldwide genetic diversity of HBV genotypes and risk of hepatocellular carcinoma. Cancer Lett 2009;286:80-88.
41. Aghokeng AF, Ayouba A, Mpoudi-Ngole E, Loul S, Liegeois F, Delaporte E, Peeters M. Extensive survey on the prevalence and genetic diversity of SIVs in primate bushmeat provides insights into risks for potential new cross-species transmissions. Infect Genet Evol 2010;10:386-396.
42. Gerlich WH, Bremer C, Saniewski M, Schuttler CG, Wend UC, Willems WR, Glebe D. Occult hepatitis B virus infection: detection and significance. Dig Dis 2010;28:116-125.
43. Wong DK, Huang FY, Lai CL, Poon RT, Seto WK, Fung J, et al. Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma. Hepatology 2011;54:829-836.
44. Gouas DA, Villar S, Ortiz-Cuaran S, Legros P, Ferro G, Kirk GD, et al. TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia. Carcinogenesis 2012;33:1219-1224.
45. Cardona NE, Loureiro CL, Garzaro DJ, Duarte MC, Garcia DM, Pacheco MC, et al. Unusual presentation of hepatitis B serological markers in an Amerindian community of Venezuela with a majority of occult cases. Virol J 2011;8:527.
46. Wiseman RW, Wojcechowskyj JA, Greene JM, Blasky AJ, Gopon T, Soma T, et al. Simian immunodeficiency virus SIVmac239 infection of major histocompatibility complex-identical cynomolgus macaques from Mauritius. J Virol 2007;81:349-361.
47. Krebs KC, Jin Z, Rudersdorf R, Hughes AL, O'Connor DH. Unusually high frequency MHC class I alleles in Mauritian origin cynomolgus macaques. J Immunol 2005;175:5230-5239.
48. O'Connor SL, Lhost JJ, Becker EA, Detmer AM, Johnson RC, Macnair CE, et al. MHC heterozygote advantage in simian immunodeficiency virus-infected Mauritian cynomolgus macaques. Sci Transl Med 2010;2:22ra18.
49. Cova L. Progress in DNA vaccination against HBV infection. Future Virology 2012;7:149.